Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€35.75
23.01.21
-
23.01.22
-73.67%
24.01.22

Could be very worthwhile Investment >20% year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.00
17.01.22
-
17.01.23
-44.67%
22.01.22

Risky Investment
buy
Biocept Inc.

Start price
Target price
Perf. (%)
€147.00
21.01.21
€3,000.0
21.01.22
-48.16%
22.01.22

Could be very worthwhile Investment >20% year
buy
Thermogenesis Holdings Inc.

Start price
Target price
Perf. (%)
€88.65
11.01.21
-
11.01.22
-53.05%
12.01.22

buy
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€30.00
04.10.21
-
04.10.22
-39.47%
10.01.22

Could be worthwhile Investment >10% per year
NanoVibronix Inc.

Start price
Target price
Perf. (%)
€52.08
13.08.21
€20.00
13.08.22
-65.13%
08.01.22

Probably not worthwhile Investment
Very low/no dividend yield expected
Little Investments for future growth
ROE lower than 10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€18.75
05.01.21
€25.00
05.01.22
-38.87%
06.01.22

buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€2.40
15.12.20
€3.00
15.12.21
-10.00%
16.12.21

buy
Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€7.40
26.11.21
-
26.11.22
-40.27%
14.12.21

buy
Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€6.40
26.11.21
-
26.11.22
14.84%
28.11.21

Vyant Bio Inc.

Start price
Target price
Perf. (%)
€9.75
01.11.20
-
04.11.21
26.15%
05.11.21

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.80
22.09.20
-
04.11.21
-49.18%
05.11.21

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
22.09.20
-
04.11.21
-49.70%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
21.09.20
-
04.11.21
-32.70%
05.11.21

buy
Lightpath Techs A

Start price
Target price
Perf. (%)
€1.86
09.09.20
€2.50
04.11.21
-8.60%
05.11.21

buy
Lightpath Techs A

Start price
Target price
Perf. (%)
€2.00
26.08.20
€3.00
04.11.21
-15.00%
05.11.21

buy
HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€57.96
24.08.20
€144.00
04.11.21
-3.52%
05.11.21

buy
Thermogenesis Holdings Inc.

Start price
Target price
Perf. (%)
€152.10
21.08.20
€157.50
04.11.21
-59.17%
05.11.21

Electrocore Inc.

Start price
Target price
Perf. (%)
€38.36
31.07.20
€14.99
04.11.21
-67.40%
05.11.21

buy
Vyant Bio Inc.

Start price
Target price
Perf. (%)
€14.10
28.06.20
-
04.11.21
-12.77%
05.11.21

Sintx Technologies Inc.

Start price
Target price
Perf. (%)
€210.00
24.06.20
€100.00
04.11.21
-50.05%
05.11.21

buy
BioLase Inc.

Start price
Target price
Perf. (%)
€11.20
16.06.20
-
04.11.21
24.87%
05.11.21

buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€2.48
14.06.20
€5.00
04.11.21
-8.87%
05.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Delcath Systems, Inc.

Start price
Target price
Perf. (%)
-
02.06.20
-
04.11.21
-
05.11.21

buy
Iridex Corp.

Start price
Target price
Perf. (%)
€1.35
17.05.20
-
04.11.21
351.85%
05.11.21